Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Minerva Neurosciences (NERV) Income from Continuing Operations (2016 - 2026)

Minerva Neurosciences filings provide 2 years of Income from Continuing Operations readings, the most recent being 21373531.0 for Q4 2021.

  • On a quarterly basis, Income from Continuing Operations fell 192.88% to 21373531.0 in Q4 2021 year-over-year; TTM through Dec 2021 was 45349141.0, a 2357.92% decrease, with the full-year FY2025 number at 14154848.0, up 31.21% from a year prior.
  • Income from Continuing Operations hit 21373531.0 in Q4 2021 for Minerva Neurosciences, down from 7513462.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 29533037.0 in Q2 2020 to a low of 21373531.0 in Q4 2021.